Lori Aschenbrenner

Director, Drug Development and Regulatory Strategy Early Phase Development Solutions


Lori Aschenbrenner earned a B.S. in Biochemistry with honors from University of Wisconsin-Madison and her Ph.D. in Biology from University of California-San Diego and holds a Board Certification in Toxicology.  She has nearly 20 years of experience in industry working among small and mid-sized biotech companies as well as large pharma.  She has a proven track record of leading and advising cross-functional teams to meet their drug development milestones.  Her drug development experience spans the preclinical stages of drug development through post marketing strategy and she is well versed in strategy across a variety of products and therapeutic areas.   In her current role at Labcorp, she provides scientific and regulatory advice to customers to maximize efficiency in their drug development journey.